{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:16:34Z","timestamp":1793744194035,"version":"4.6.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T00:00:00Z","timestamp":1622160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T00:00:00Z","timestamp":1622160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s12325-021-01789-5","type":"journal-article","created":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T12:02:49Z","timestamp":1622203369000},"page":"3842-3856","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Acetyl-l-Carnitine Ameliorates Metabolic and Endocrine Alterations in Women with PCOS: A Double-Blind Randomized Clinical Trial"],"prefix":"10.1007","volume":"38","author":[{"given":"Saman","family":"Tauqir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Momina","family":"Israr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bushra","family":"Rauf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Omar","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Hamid","family":"Habib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fawad Ali","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Usman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Asif","family":"Raza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inayat","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haroon","family":"Badshah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehtesham","family":"Ehtesham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9017-9152","authenticated-orcid":false,"given":"Mohsin","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,28]]},"reference":[{"issue":"9","key":"1789_CR1","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1093\/humrep\/dey256","volume":"33","author":"HJ Teede","year":"2018","unstructured":"Teede HJ, Misso ML, Costello MF, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018;33(9):1602\u201318.","journal-title":"Hum Reprod"},{"key":"1789_CR2","first-page":"e0123608","volume":"4","author":"MB Khomami","year":"2015","unstructured":"Khomami MB, Tehrani FR, Hashemi S, Farahmand M, Azizi F. Of PCOS symptoms, hirsutism has the most significant impact on the quality of life of Iranian women. PLoS One. 2015;10(4):e0123608.","journal-title":"10"},{"issue":"1","key":"1789_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1741-7015-8-41","volume":"8","author":"H Teede","year":"2010","unstructured":"Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010;8(1):41.","journal-title":"BMC Med"},{"issue":"9","key":"1789_CR4","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1093\/humrep\/der197","volume":"26","author":"JA Barry","year":"2011","unstructured":"Barry JA, Kuczmierczyk AR, Hardiman PJ. Anxiety and depression in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2011;26(9):2442\u201351.","journal-title":"Hum Reprod"},{"issue":"6","key":"1789_CR5","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1093\/humupd\/dms029","volume":"18","author":"SM Veltman-Verhulst","year":"2012","unstructured":"Veltman-Verhulst SM, Boivin J, Eijkemans MJ, Fauser BJ. Emotional distress is a common risk in women with polycystic ovary syndrome: a systematic review and meta-analysis of 28 studies. Hum Reprod Update. 2012;18(6):638\u201351.","journal-title":"Hum Reprod Update"},{"issue":"9","key":"1789_CR6","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1017\/S0033291718002076","volume":"49","author":"AL Damone","year":"2019","unstructured":"Damone AL, Joham AE, Loxton D, Earnest A, Teede HJ, Moran LJ. Depression, anxiety and perceived stress in women with and without PCOS: a community-based study. Psychol Med. 2019;49(9):1510\u201320.","journal-title":"Psychol Med"},{"issue":"9","key":"1789_CR7","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1093\/humrep\/del146","volume":"21","author":"HF Escobar-Morreale","year":"2006","unstructured":"Escobar-Morreale HF, Villuendas G, Botella-Carretero JI, et al. Adiponectin and resistin in PCOS: a clinical, biochemical and molecular genetic study. Hum Reprod. 2006;21(9):2257\u201365.","journal-title":"Hum Reprod"},{"issue":"2","key":"1789_CR8","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1530\/eje.1.02207","volume":"155","author":"D Glintborg","year":"2006","unstructured":"Glintborg D, Andersen M, Hagen C, et al. Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls. Eur J Endocrinol. 2006;155(2):337\u201345.","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"1789_CR9","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1111\/j.1365-2265.2004.02159.x","volume":"61","author":"J Spranger","year":"2004","unstructured":"Spranger J, M\u00f6hlig M, Wegewitz U, et al. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome. Clin Endocrinol (Oxf). 2004;61(6):738\u201346.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"1789_CR10","first-page":"89","volume":"6","author":"K Cusi","year":"1998","unstructured":"Cusi K, Defronzo RA. Metformin: a review of its metabolic effects. Diabetes Rev. 1998;6(2):89\u2013131.","journal-title":"Diabetes Rev"},{"issue":"2","key":"1789_CR11","doi-asserted-by":"publisher","first-page":"333","DOI":"10.2165\/00003495-200060020-00009","volume":"60","author":"PS Gillies","year":"2000","unstructured":"Gillies PS, Dunn CJ. Pioglitazone. Drugs. 2000;60(2):333\u201343.","journal-title":"Drugs"},{"issue":"4","key":"1789_CR12","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2174\/1568015033477659","volume":"3","author":"Z Binienda","year":"2003","unstructured":"Binienda Z, Virmani A. The mitochondriotropic effects of L-carnitine and its esters in the central nervous system. Curr Med Chem-Cent Nerv Syst Agents. 2003;3(4):275\u201382.","journal-title":"Curr Med Chem-Cent Nerv Syst Agents"},{"issue":"1","key":"1789_CR13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1196\/annals.1320.011","volume":"1033","author":"J Liu","year":"2004","unstructured":"Liu J, Head E, Kuratsune H, Cotman CW, Ames BN. Comparison of the effects of L-carnitine and acetyl-L-carnitine on carnitine levels, ambulatory activity, and oxidative stress biomarkers in the brain of old rats. Ann NY Acad Sci. 2004;1033(1):117\u201331.","journal-title":"Ann NY Acad Sci"},{"issue":"10","key":"1789_CR14","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1016\/j.bbamcr.2016.01.023","volume":"1863","author":"N Longo","year":"2016","unstructured":"Longo N, Frigeni M, Pasquali M. Carnitine transport and fatty acid oxidation. Biochim Biophys Acta. 2016;1863(10):2422\u201335.","journal-title":"Biochim Biophys Acta"},{"key":"1789_CR15","first-page":"28","volume":"1","author":"NAM Ibrahim","year":"2020","unstructured":"Ibrahim NAM, Mansour YSE, Sulieman A, Hussein HS. A local study on the effects of L-carnitine supplement on serum lipid profiles in Libyan type 2 diabetic patients. IJARW. 2020;1:28\u201332.","journal-title":"IJARW"},{"issue":"2","key":"1789_CR16","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3177\/jnsv.66.136","volume":"66","author":"S Odo","year":"2020","unstructured":"Odo S, Tanabe K, Yohda M, Yamauchi M. Liver-oriented acute metabolic effects of a low dose of l-carnitine under fat-mobilizing conditions: pilot human clinical trial. J Nutr Sci Vitaminol (Tokyo). 2020;66(2):136\u201349.","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"issue":"5","key":"1789_CR17","doi-asserted-by":"publisher","first-page":"4138","DOI":"10.21608\/ejhm.2019.43079","volume":"76","author":"AT Abd-Elfattah","year":"2019","unstructured":"Abd-Elfattah AT, Elomda FAE-A, Hashish MA-E, Megahed HI. Effect of adding L-carnitine to clomiphene resistant PCOs women on the ovulation and the pregnancy rate. Egypt J Hosp Med. 2019;76(5):4138\u201343.","journal-title":"Egypt J Hosp Med"},{"key":"1789_CR18","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.ebiom.2019.10.017","volume":"49","author":"YM Bruls","year":"2019","unstructured":"Bruls YM, de Ligt M, Lindeboom L, et al. Carnitine supplementation improves metabolic flexibility and skeletal muscle acetylcarnitine formation in volunteers with impaired glucose tolerance: a randomised controlled trial. EBioMedicine. 2019;49:318\u201330.","journal-title":"EBioMedicine"},{"issue":"11","key":"1789_CR19","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1093\/humrep\/14.11.2720","volume":"14","author":"E Kousta","year":"1999","unstructured":"Kousta E, White DM, Cela E, McCarthy MI, Franks S. The prevalence of polycystic ovaries in women with infertility. Hum Reprod. 1999;14(11):2720\u20133.","journal-title":"Hum Reprod"},{"issue":"6","key":"1789_CR20","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1080\/09513590.2017.1290071","volume":"33","author":"H Jamilian","year":"2017","unstructured":"Jamilian H, Jamilian M, Samimi M, et al. Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Gynecol Endocrinol. 2017;33(6):442\u20137.","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"1789_CR21","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0021-5198(19)30606-7","volume":"83","author":"T Ishii","year":"2000","unstructured":"Ishii T, Shimpo Y, Matsuoka Y, Kinoshita K. Anti-apoptotic effect of acetyl-L-carnitine and L-carnitine in primary cultured neurons. Jpn J Pharmacol. 2000;83(2):119\u201324.","journal-title":"Jpn J Pharmacol"},{"key":"1789_CR22","doi-asserted-by":"publisher","first-page":"102273","DOI":"10.1016\/j.ctim.2019.102273","volume":"48","author":"M Abolfathi","year":"2020","unstructured":"Abolfathi M, Mohd-Yusof B-N, Hanipah ZN, Redzwan SM, Yusof LM, Khosroshahi MZ. The effects of carnitine supplementation on clinical characteristics of patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials. Complement Ther Med. 2020;48:102273.","journal-title":"Complement Ther Med"},{"issue":"5\u20136","key":"1789_CR23","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.mam.2004.06.006","volume":"25","author":"A Steiber","year":"2004","unstructured":"Steiber A, Kerner J, Hoppel CL. Carnitine: a nutritional, biosynthetic, and functional perspective. Mol Aspects Med. 2004;25(5\u20136):455\u201373.","journal-title":"Mol Aspects Med"},{"issue":"7","key":"1789_CR24","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1093\/humrep\/den109","volume":"23","author":"SM Fenkci","year":"2008","unstructured":"Fenkci SM, Fenkci V, Oztekin O, Rota S, Karagenc N. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome. Hum Reprod. 2008;23(7):1602\u20136.","journal-title":"Hum Reprod"},{"issue":"4","key":"1789_CR25","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0960-0760(92)90170-N","volume":"43","author":"LZ Krsmanovi\u0107","year":"1992","unstructured":"Krsmanovi\u0107 LZ, Virmani MA, Stojilkovi\u0107 SS, Catt KJ. Actions of acetyl-L-carnitine on the hypothalamo-pituitary-gonadal system in female rats. J Steroid Biochem Mol Biol. 1992;43(4):351\u20138.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"4","key":"1789_CR26","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/BF03347087","volume":"34","author":"A Genazzani","year":"2011","unstructured":"Genazzani A, Lanzoni C, Ricchieri F, et al. Acetyl-L-carnitine (ALC) administration positively affects reproductive axis in hypogonadotropic women with functional hypothalamic amenorrhea. J Endocrinol Invest. 2011;34(4):287\u201391.","journal-title":"J Endocrinol Invest"},{"issue":"9","key":"1789_CR27","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1016\/j.theriogenology.2015.01.028","volume":"83","author":"KL Reader","year":"2015","unstructured":"Reader KL, Cox NR, Stanton J-AL, Juengel JL. Effects of acetyl-L-carnitine on lamb oocyte blastocyst rate, ultrastructure, and mitochondrial DNA copy number. Theriogenology. 2015;83(9):1484\u201392.","journal-title":"Theriogenology"},{"issue":"1","key":"1789_CR28","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1055\/s-2007-992925","volume":"26","author":"DA Dumesic","year":"2008","unstructured":"Dumesic DA, Abbott DH. Implications of polycystic ovary syndrome (PCOS) on oocyte development. Semin Reprod Med. 2008;26(1):53\u201361.","journal-title":"Semin Reprod Med."},{"issue":"12","key":"1789_CR29","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1093\/humrep\/dex330","volume":"32","author":"T Truong","year":"2017","unstructured":"Truong T, Gardner D. Antioxidants improve IVF outcome and subsequent embryo development in the mouse. Hum Reprod. 2017;32(12):2404\u201313.","journal-title":"Hum Reprod"},{"issue":"9","key":"1789_CR30","doi-asserted-by":"publisher","first-page":"867","DOI":"10.3390\/antiox9090867","volume":"9","author":"G Di Emidio","year":"2020","unstructured":"Di Emidio G, Rea F, Placidi M, et al. Regulatory functions of L-carnitine, acetyl, and propionyl L-carnitine in a PCOS mouse model: focus on antioxidant\/antiglycative molecular pathways in the ovarian microenvironment. Antioxidants. 2020;9(9):867.","journal-title":"Antioxidants"},{"key":"1789_CR31","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ejogrb.2014.06.008","volume":"180","author":"AM Ismail","year":"2014","unstructured":"Ismail AM, Hamed AH, Saso S, Thabet HH. Adding L-carnitine to clomiphene resistant PCOS women improves the quality of ovulation and the pregnancy rate. A randomized clinical trial. Eur J Obstet Gynecol Reprod Biol. 2014;180:148\u201352.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"1789_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7827-11-67","volume":"11","author":"\u00c1 V\u00e1rnagy","year":"2013","unstructured":"V\u00e1rnagy \u00c1, Bene J, Sulyok E, Kov\u00e1cs GL, B\u00f3dis J, Melegh B. Acylcarnitine esters profiling of serum and follicular fluid in patients undergoing in vitro fertilization. Reprod Biol Endocrinol. 2013;11(1):1\u20139.","journal-title":"Reprod Biol Endocrinol"},{"issue":"3","key":"1789_CR33","doi-asserted-by":"publisher","first-page":"236","DOI":"10.21608\/ebwhj.2018.15474","volume":"8","author":"Y Edris","year":"2018","unstructured":"Edris Y, Barakat E. Supplementation with L-carnitine improves uterine receptivity in women with prior implantation failure during frozen embryos transfer: A double-blinded, randomized, placebo-controlled clinical trial. Evid Based Women\u2019s Health J. 2018;8(3):236\u201344.","journal-title":"Evid Based Women's Health J"},{"issue":"1\u20132","key":"1789_CR34","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.anireprosci.2012.08.013","volume":"134","author":"KR Dunning","year":"2012","unstructured":"Dunning KR, Robker RL. Promoting lipid utilization with l-carnitine to improve oocyte quality. Anim Reprod Sci. 2012;134(1\u20132):69\u201375.","journal-title":"Anim Reprod Sci"},{"issue":"8","key":"1789_CR35","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1080\/09513590.2019.1576622","volume":"35","author":"I El Sharkwy","year":"2019","unstructured":"El Sharkwy I, Sharaf E-D. l-Carnitine plus metformin in clomiphene-resistant obese PCOS women, reproductive and metabolic effects: a randomized clinical trial. Gynecol Endocrinol. 2019;35(8):701\u20135.","journal-title":"Gynecol Endocrinol"},{"issue":"6","key":"1789_CR36","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1111\/cen.13003","volume":"84","author":"M Samimi","year":"2016","unstructured":"Samimi M, Jamilian M, Ebrahimi FA, Rahimi M, Tajbakhsh B, Asemi Z. Oral carnitine supplementation reduces body weight and insulin resistance in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Clin Endocrinol (Oxf). 2016;84(6):851\u20137.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"1789_CR37","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2307\/2136404","volume":"24","author":"S Cohen","year":"1983","unstructured":"Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24(4):385\u201396.","journal-title":"J Health Soc Behav."},{"key":"1789_CR38","first-page":"93","volume":"2","author":"JR Grove","year":"1992","unstructured":"Grove JR, Prapavessis H. Preliminary evidence for the reliability and validity of an abbreviated profile of mood states. Int J Sport Psychol. 1992;23(2):93\u2013109.","journal-title":"23"},{"key":"1789_CR39","first-page":"Doc06","volume":"4","author":"M Morfeld","year":"2007","unstructured":"Morfeld M, Petersen C, Kr\u00fcger-B\u00f6deker A, Von Mackensen S, Bullinger M. The assessment of mood at workplace-psychometric analyses of the revised Profile of Mood States (POMS) questionnaire. GMS Psycho-Social Med. 2007;4:Doc06.","journal-title":"GMS Psycho-Social Med."},{"issue":"2","key":"1789_CR40","first-page":"103","volume":"49","author":"M Zahra","year":"2017","unstructured":"Zahra M, Shah M, Ali A, Rahim R. Effects of metformin on endocrine and metabolic parameters in patients with polycystic ovary syndrome. Horm Metab Res. 2017;49(2):103\u20138.","journal-title":"Horm Metab Res"},{"issue":"11","key":"1789_CR41","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1055\/a-1018-9606","volume":"51","author":"M Shah","year":"2019","unstructured":"Shah M, Ali A, Malik MO, et al. Treatment with metformin and combination of metformin plus pioglitazone on serum levels of IL-6 and IL-8 in polycystic ovary syndrome: a randomized clinical trial. Horm Metab Res. 2019;51(11):714\u201322.","journal-title":"Horm Metab Res"},{"issue":"1","key":"1789_CR42","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/ijgo.12902","volume":"147","author":"IA El Sharkwy","year":"2019","unstructured":"El Sharkwy IA, El Aziz AWM. Randomized controlled trial of N-acetylcysteine versus l-carnitine among women with clomiphene-citrate-resistant polycystic ovary syndrome. Int J Gynecol Obstet. 2019;147(1):59\u201364.","journal-title":"Int J Gynecol Obstet"},{"issue":"4","key":"1789_CR43","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/sj.ejcn.1602109","volume":"59","author":"A Rahbar","year":"2005","unstructured":"Rahbar A, Shakerhosseini R, Saadat N, Taleban F, Pordal A, Gollestan B. Effect of L-carnitine on plasma glycemic and lipidemic profile in patients with type II diabetes mellitus. Eur J Clin Nutr. 2005;59(4):592\u20136.","journal-title":"Eur J Clin Nutr"},{"issue":"5","key":"1789_CR44","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1093\/humrep\/dex044","volume":"32","author":"LG Cooney","year":"2017","unstructured":"Cooney LG, Lee I, Sammel MD, Dokras A. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2017;32(5):1075\u201391.","journal-title":"Hum Reprod"},{"issue":"8","key":"1789_CR45","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1111\/jog.12696","volume":"41","author":"BB Annag\u00fcr","year":"2015","unstructured":"Annag\u00fcr BB, Kerimoglu \u00d6S, Tazeg\u00fcl A, G\u00fcnd\u00fcz \u015e, Gen\u00e7oglu BB. Psychiatric comorbidity in women with polycystic ovary syndrome. J Obstet Gynaecol Res. 2015;41(8):1229\u201333.","journal-title":"J Obstet Gynaecol Res"},{"issue":"4","key":"1789_CR46","first-page":"305","volume":"50","author":"R Hart","year":"2008","unstructured":"Hart R. PCOS and infertility. Panminerva Med. 2008;50(4):305\u201314.","journal-title":"Panminerva Med"},{"issue":"12","key":"1789_CR47","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1017\/S0007114512004369","volume":"109","author":"Y-H Tsai","year":"2013","unstructured":"Tsai Y-H, Wang T-W, Wei H-J, et al. Dietary intake, glucose metabolism and sex hormones in women with polycystic ovary syndrome (PCOS) compared with women with non-PCOS-related infertility. Br J Nutr. 2013;109(12):2190\u20138.","journal-title":"Br J Nutr"},{"issue":"2","key":"1789_CR48","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1089\/jwh.2006.0098","volume":"16","author":"EO Talbott","year":"2007","unstructured":"Talbott EO, Zborowski JV, Rager JR, Kip KE, Xu X, Orchard TJ. Polycystic ovarian syndrome (PCOS): a significant contributor to the overall burden of type 2 diabetes in women. J Womens Health. 2007;16(2):191\u20137.","journal-title":"J Womens Health"},{"issue":"1","key":"1789_CR49","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1159\/000194971","volume":"2","author":"J Vrbikova","year":"2009","unstructured":"Vrbikova J, Hainer V. Obesity and polycystic ovary syndrome. Obes Facts. 2009;2(1):26\u201335.","journal-title":"Obes Facts"},{"issue":"3","key":"1789_CR50","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1161\/HYPERTENSIONAHA.109.132522","volume":"54","author":"P Ruggenenti","year":"2009","unstructured":"Ruggenenti P, Cattaneo D, Loriga G, et al. Ameliorating hypertension and insulin resistance in subjects at increased cardiovascular risk: effects of acetyl-L-carnitine therapy. Hypertension. 2009;54(3):567\u201374.","journal-title":"Hypertension"},{"issue":"8","key":"1789_CR51","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1017\/S0007114509389230","volume":"102","author":"C Mingorance","year":"2009","unstructured":"Mingorance C, del Pozo MG, Herrera MD, de Sotomayor MA. Oral supplementation of propionyl-l-carnitine reduces body weight and hyperinsulinaemia in obese Zucker rats. Br J Nutr. 2009;102(8):1145\u201353.","journal-title":"Br J Nutr"},{"issue":"1","key":"1789_CR52","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1743-7075-6-25","volume":"6","author":"RJ Bloomer","year":"2009","unstructured":"Bloomer RJ, Fisher-Wellman KH, Tucker PS. Effect of oral acetyl L-carnitine arginate on resting and postprandial blood biomarkers in pre-diabetics. Nutr Metab. 2009;6(1):25.","journal-title":"Nutr Metab"},{"issue":"6","key":"1789_CR53","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1053\/meta.2000.6250","volume":"49","author":"A Giancaterini","year":"2000","unstructured":"Giancaterini A, De Gaetano A, Mingrone G, et al. Acetyl-L-carnitine infusion increases glucose disposal in type 2 diabetic patients. Metabolism. 2000;49(6):704\u20138.","journal-title":"Metabolism"},{"issue":"6","key":"1789_CR54","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1111\/j.1939-1676.2000.tb02283.x","volume":"14","author":"S Center","year":"2000","unstructured":"Center S, Harte J, Watrous D, et al. The clinical and metabolic effects of rapid weight loss in obese pet cats and the influence of supplemental oral L-carnitine. J Vet Intern Med. 2000;14(6):598\u2013608.","journal-title":"J Vet Intern Med"},{"issue":"9","key":"1789_CR55","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1093\/humrep\/deg353","volume":"18","author":"D Panidis","year":"2003","unstructured":"Panidis D, Kourtis A, Farmakiotis D, Mouslech T, Rousso D, Koliakos G. Serum adiponectin levels in women with polycystic ovary syndrome. Hum Reprod. 2003;18(9):1790\u20136.","journal-title":"Hum Reprod"},{"issue":"2\u20133","key":"1789_CR56","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0014-2999(02)01430-9","volume":"440","author":"T-S Tsao","year":"2002","unstructured":"Tsao T-S, Lodish HF, Fruebis J. ACRP30, a new hormone controlling fat and glucose metabolism. Eur J Pharmacol. 2002;440(2\u20133):213\u201321.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"1789_CR57","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/S1043-2760(01)00524-0","volume":"13","author":"AH Berg","year":"2002","unstructured":"Berg AH, Combs TP, Scherer PE. ACRP30\/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab. 2002;13(2):84\u20139.","journal-title":"Trends Endocrinol Metab"},{"issue":"6","key":"1789_CR58","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1177\/2042018811423770","volume":"2","author":"B Pangaribuan","year":"2011","unstructured":"Pangaribuan B, Yusuf I, Mansyur M, Wijaya A. Serum adiponectin and resistin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome. Ther Adv Endocrinol Metab. 2011;2(6):235\u201345.","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"2","key":"1789_CR59","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2337\/diabetes.52.2.239","volume":"52","author":"O Tschritter","year":"2003","unstructured":"Tschritter O, Fritsche A, Thamer C, et al. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes. 2003;52(2):239\u201343.","journal-title":"Diabetes"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-021-01789-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-021-01789-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-021-01789-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T16:38:43Z","timestamp":1628613523000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-021-01789-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,28]]},"references-count":59,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["1789"],"URL":"https:\/\/doi.org\/10.1007\/s12325-021-01789-5","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,28]]},"assertion":[{"value":"1 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}